Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Jinghai Weixiang Biomaterials

Request full access

AI-driven synthetic biology for bio-based materials.

ChinaFounded 2020Chemicals

About Jinghai Weixiang Biomaterials

Jinghai Weixiang Biomaterials, operating as Gwalrus Biomaterials, is a high-tech enterprise founded in 2020. The company focuses on the complete industrial-chain innovation of bio-based materials, integrating AI, synthetic biology, and material science. Gwalrus Biomaterials has developed a closed-loop system that transforms non-food biomass into polylactic acid (PLA) and its subsequent products, also incorporating recycling of PLA (rPLA). The process encompasses the conversion of biomass to lactic acid, then to lactide, and finally to PLA. This strategy positions the company as a key player in the green, low-carbon bio-manufacturing sector. The company has made significant technological advancements across its production chain. Notable breakthroughs include a "gypsum-free lactic acid technology," which resolves the environmental issue of large-scale solid waste generated in traditional lactic acid production. Other key innovations are in non-food biomass utilization and the development of next-generation industrial strains. In early 2026, Gwalrus Biomaterials secured approximately 100 million in a Series B financing round, led exclusively by Jiazhi Fund. This funding is aimed at expanding the production capacity of its large-scale base, advancing research and development of next-generation technologies, and growing its market presence. The company is also preparing for a subsequent Series B+ financing round.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
18.0/100
Industry
Chemicals
Sector
Biotechnology, Biomaterials, Core AI, Synthetic Biology, Advanced Materials, Bioplastic, DT and LS, science-based
Technology
Artificial Intelligence, Deep Tech
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Jan 2026 $14M $55M Undisclosed ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Jinghai Weixiang Biomaterials in its local ecosystem

Live from Dealroom

The Jinghai Weixiang Biomaterials office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Jinghai Weixiang Biomaterials on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Jinghai Weixiang Biomaterials’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.